Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background: Bipolar disorder is a mental health condition with progressive social and cognitive function disturbances. Most patients' treatments are based on polypharmacy, but with no biological basis and little is known of the drugs' interactions. The aim of this study was to analyze the effects of lithium, valproate, quetiapine, and lamotrigine, and the interactions between them, on markers of inflammation, bioenergetics, mitochondrial function, and oxidative stress in neuron-like cells and microglial cells. Methods: Neuron-like cells and lipopolysaccharide-stimulated C8-B4 cells were treated with lithium (2.5 mM), valproate (0.5 mM), quetiapine (0.05 mM), and lamotrigine (0.05 mM) individually and in all possible combinations for 24 h. Twenty cytokines were measured in the media from lipopolysaccharide-stimulated C8-B4 cells. Metabolic flux analysis was used to measure bioenergetics, and real-time PCR was used to measure the expression of mitochondrial function genes in neuron-like cells. The production of superoxide in treated cells was also assessed. Results: The results suggest major inhibitory effects on proinflammatory cytokine release as a therapeutic mechanism of these medications when used in combination. The various combinations of medications also caused overexpression of PGC1α and ATP5A1 in neuron-like cells. Quetiapine appears to have a proinflammatory effect in microglial cells, but this was reversed by the addition of lamotrigine independent of the drug combination. Conclusion: Polypharmacy in bipolar disorder may have antiinflammatory effects on microglial cells as well as effects on mitochondrial biogenesis in neuronal cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Aerobic respiration and glycolysis in differentiated NT2-N cells as determined by oxygen consumption rate flux in response to mitochondrial probes (for oxygen consumption rate [OCR]) and by flux bioanalysis (for extracellular acidification rate [ECAR]). Data represented as mean OCR (pmol/min) or ECAR (pM/min)±SEM; n=4 to 6 per group. *P<.05 compared with vehicle treated cells (descriptive statistical test).](https://figures.cochat.ai/paper-figures/851090aabc6d4435aba421556adecb99/mechanisms-underpinning-the-polypharmacy-effects-of-medications-in-psychiatry-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bartolasci et al. (2018) suggested that mood stabilizers, such as lithium, VPA, LTG, and quetiapine, which are commonly used in the treatment of BD, may exert varying effects on inflammatory processes depending on their combinations (Bortolasci et al. 2018).”
From Mood stabilizers and systemic inflammatory burden in euthymic patients with bipolar disorder: a comparative study of lithium and valproate (2026) · doi:10.1007/s00213-026-07111-x · cites this paper as Bortolasci et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: From neurons to microglia, with complements
Derecki, N. C., & Kipnis, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3579 · Cited by 9 · cited 1×
“Microglia are activated by various neuropathological states and can, in response, secrete proinflammatory cytokines (Derecki and Kipnis, 2013).”
BackgroundRetractedMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 2×
“Suppression of microglia-mediated inflammation has been proposed as a strategy in therapy as prolonged immune activation can damage neuronal structure through the production of elevated levels of reactive oxygen species (ROS) and neurotoxins (Block et al., 2007; Czeh et al., 2011).”
BackgroundBerk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationOxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928 · cited 1×
“Operant biological pathways may include mitochondrial dysfunction, alterations in circulating levels of proinflammatory cytokines, neurotrophins, and oxidative stress (OS) (Bhat et al., 2015).”
BackgroundPleasure, S., Page, C., & Lee, V. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01802.1992 · Cited by 608 · cited 1×
“These cells are known to express a neuron-like phenotype following retinoic acid-induced differentiation (Pleasure et al., 1992).”
BackgroundCytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596 · cited 3×
“(2013) in a meta-analysis provided evidence for a lack of medication effect on plasma concentrations of IL-2, IL-4, sIL-6R, and INF-γ (Modabbernia et al., 2013).”
BackgroundInfluentialThe role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594 · cited 1×
“BD is associated with inflammation in the periphery and in the central nervous system, and there is increasing evidence to suggest that activation of microglia is a key element in this process (Block et al., 2007; Reus et al., 2015).”
BackgroundInflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584 · cited 2×
“In particular, inflammatory mediators might act through glial cells to regulate extracellular glutamate concentrations in both physiological and pathological conditions (Haroon et al., 2017).”
BackgroundMolecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Konradi, C., Eaton, M., MacDonald, M. L., Walsh, J., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 501 · cited 1×
“Mitochondrial dysregulation associated with decreased oxidative phosphorylation shifts metabolism toward anaerobic energy production via glycolysis, increasing lactate levels and pH and leading to production of ROS, glutamate excitotoxicity, and apoptosis (Konradi et al., 2004).”
BackgroundImbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375 · cited 1×
“Some studies showed a reduction in IFN-γ peripherally within 6 weeks of treatment (Kim et al., 2007; Uyanik et al., 2015).”
BackgroundCzeh, M., Gressens, P., & Kaindl, A. M. (2011) · Developmental Neuroscience · doi:10.1159/000328989 · Cited by 321 · cited 1×
“Suppression of microglia-mediated inflammation has been proposed as a strategy in therapy as prolonged immune activation can damage neuronal structure through the production of elevated levels of reactive oxygen species (ROS) and neurotoxins (Block et al., 2007; Czeh et al., 2011).”
BackgroundPGC-1α and PGC-1Β Regulate Mitochondrial Density in Neurons
Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M., & Kaasik, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018911 · Cited by 294 · cited 2×
“*P < .05 compared with vehicle treated cells (descriptive statistical test). biogenesis and cellular energy metabolism (Wareski et al., 2009; Markham et al., 2014).”
BackgroundCytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · cited 1×
“(2013) reviewed 10 studies on the association between plasma cytokine levels and medicines; of these, 6 studies did not find any significant correlation between medication status and cytokine levels, and 4 studies demonstrated correlations for individual cytokine parameters, of which none were replicated (Munkholm et…”
BackgroundShao, L., Young, L. T., & Wang, J.-F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.052 · Cited by 218 · cited 1×
“Quetiapine has previously been reported to have antioxidant properties (Shao et al., 2005; Wang et al., 2005), so it is likely that the decrease in basal oxygen consumption seen in the present study was associated with decreased ROS production.”
BackgroundRosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · cited 1×
“of combination of these drugs includes an antiinflammatory effect is supported by a recent meta-analysis showing that nonsteroidal antiinflammatory drugs have a moderate antidepressant effect in subjects with bipolar disorder (Rosenblat et al., 2016).”
ResultSelf-citationPolarity index of pharmacological agents used for maintenance treatment of bipolar disorder
Popovic, D., Reinares, M., Goikolea, J. M., Bonnin, C. M., Gonzalez-Pinto, A., & Vieta, E. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.008 · Cited by 187 · cited 1×
“Following the polarity index of drugs, anticonvulsants (particularly lamotrigine) seem more effective for prevention of depressive episodes, while atypical antipsychotics and lithium may have a manic polarity index of efficacy (Popovic et al., 2012).”
BackgroundScaini, G., Rezin, G. T., Carvalho, A. F., Streck, E. L., Berk, M., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.040 · Cited by 179 · cited 1×
“mitochondrial DNA polymorphisms; and downregulation of nuclear mRNA molecules and proteins involved in mitochondrial respiration (Scaini et al., 2016).”
BackgroundSelf-citationOxidative stress in early stage Bipolar Disorder and the association with response to lithium
de Sousa, R. T., Zarate, C. A., Zanetti, M. V., Costa, A. C., Talib, L. L., Gattaz, W. F., & Machado-Vieira, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.011 · Cited by 169
Goldberg, J. F., Brooks, J. O., Kurita, K., Hoblyn, J. C., Ghaemi, S. N., Perlis, R. H., Miklowitz, D. J., Ketter, T. A., Sachs, G. S., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04301 · Cited by 145 · cited 2×
“The majority of patients treated for BD receive multiple psychotropic medications concurrently (Goldberg et al., 2009; Sachs et al., 2014).”
BackgroundMethodLithium‐induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue
Maurer, I. C., Schippel, P., & Volz, H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00729.x · Cited by 136 · cited 2×
“The activity of complex IV was unaffected, suggesting that lithium selectively increases the activity of specific enzymes, rather than acting as a general stimulator of the electron transport chain (Maurer et al., 2009).”
BackgroundValvassori, S. S., Rezin, G. T., Ferreira, C. L., Moretti, M., Gonçalves, C. L., Cardoso, M. R., STRECK, E. L., Kapczinski, F. P., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.009 · Cited by 127 · cited 1×
“A recent study showed that valproate reversed the methamphetamine-induced inhibition of complexes I, II, III, and IV in rat brains (Valvassori et al., 2010).”
BackgroundNeurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond
Kato, T. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.037 · Cited by 126 · cited 2×
“…of mitochondria-related genes, increase of lactate in the brain, decrease of complex I in postmortem brains, abnormal mitochondrial structure in cells of bipolar patients, and elevation of isocitrate in cerebrospinal fluid associated with impaired function of isocitrate dehydrogenase (Kato, 2017).”
BackgroundMarkham, A., Bains, R., Franklin, P., & Spedding, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 111 · cited 1×
“*P < .05 compared with vehicle treated cells (descriptive statistical test). biogenesis and cellular energy metabolism (Wareski et al., 2009; Markham et al., 2014).”
BackgroundWang, H., Xu, H., Dyck, L. E., & Li, X.-M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20570 · Cited by 94
Sárvári, A. K., Veréb, Z., Uray, I. P., Fésüs, L., & Balajthy, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.005 · Cited by 91
Decreased global methylation in patients with bipolar disorder who respond to lithium
Huzayyin, A. A., Andreazza, A. C., Turecki, G., Cruceanu, C., Rouleau, G. A., Alda, M., & Young, L. T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001569 · Cited by 80
Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment
Uyanik, V., Tuğlu, C., Görgülü, Y., Kunduracılar, H., & Uyanık, M. Ş. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.078 · Cited by 73 · cited 1×
“Some studies showed a reduction in IFN-γ peripherally within 6 weeks of treatment (Kim et al., 2007; Uyanik et al., 2015).”
BackgroundThe effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review
van den Ameele, S., van Diermen, L., Staels, W., Coppens, V., Dumont, G. J. H., Sabbe, B., & Morrens, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.016 · Cited by 73
Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method
Megiorni, F., Mora, B., Indovina, P., & Mazzilli, M. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.070 · Cited by 66 · cited 1×
“Neuronal markers such as NeuroD (neuronal differentiation), GluR (glutamate receptor), and Tau (cytoskeletal protein) were measured by realtime PCR (RT-PCR) to confirm the neuronal-like state of the cells (data not shown) (Megiorni et al., 2005).”
MethodMitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
Martin, S. D., Morrison, S., Konstantopoulos, N., & McGee, S. L. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.001 · Cited by 58 · cited 1×
“Calculations of respiratory parameters of mitochondrial function were performed as previously described (Martin et al., 2014).”
MethodSelf-citationKinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
Naaldijk, Y., Bittencourt, M. C., Sack, U., & Ulrich, H. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0257 · Cited by 51
Is bipolar disorder a mitochondrial disease?
Young, L. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0715 · Cited by 50
Polypharmacy and bipolar disorder: what's personality got to do with it?
Sachs, G. S., Peters, A. T., Sylvia, L., & Grunze, H. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000953 · Cited by 45 · cited 2×
“The majority of patients treated for BD receive multiple psychotropic medications concurrently (Goldberg et al., 2009; Sachs et al., 2014).”
BackgroundTsai, S., Chung, K., Huang, S., Chen, P., Lee, H., & Kuo, C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12240 · Cited by 43 · cited 1×
“Medications prescribed for BD may have plentiful drugdrug interactions, raising safety concerns about polypharmacy and reiterating the need for biologically based evidence (Tsai et al., 2014).”
BackgroundRizig, M. A., McQuillin, A., Ng, A., Robinson, M., Harrison, A., Zvelebil, M., Hunt, S. P., & Gurling, H. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112450780 · Cited by 39 · cited 1×
“Most useful psychotropic medications produce maximal responses after several weeks, and this observation indicates that chronic adaptive molecular changes are crucial components of successful treatment rather than simple immediate receptor binding effects (Rizig et al., 2012).”
BackgroundResting energy expenditure in manic episode
Caliyurt, O., & Altiay, G. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00649.x · Cited by 35 · cited 1×
“There is evidence of increased basal metabolic rate in mania (Caliyurt and Altiay, 2009) and decreased bioenergetics in depression, concordant with a biphasic model of energy generation in BD paralleling symptomatology.”
BackgroundUse of polypharmacy and self-reported mood in outpatients with bipolar disorder
Adli, M., Whybrow, P. C., Grof, P., Rasgon, N., Gyulai, L., Baethge, C., Glenn, T., & Bauer, M. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500510029200 · Cited by 19 · cited 1×
“For individuals with BD, these typically include agents such as mood stabilizers, atypical antipsychotics, antidepressants, and benzodiazepines (Adli et al., 2005).”
BackgroundRicken, R., Busche, M., Schlattmann, P., Himmerich, H., Bopp, S., Bschor, T., Richter, C., Stamm, T. J., Heinz, A., Hellweg, R., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.10.002 · Cited by 17 · cited 1×
“(2018) recently published a study showing the treatment with lithium does not change cytokine serum levels (IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, INF-γ), even after augmentation (Ricken et al., 2018).”
BackgroundDuong, A., Che, Y., Ceylan, D., Pinguelo, A., Andreazza, A. C., Young, L. T., & Berk, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.015 · Cited by 13 · cited 1×
“This disorder is ranked in the top 10 leading causes of lifelong disability worldwide according the World Health Organization and affects approximately 2% of the population (Duong et al., 2016; Rihmer et al., 2016).”
BackgroundSelf-citationRihmer, Z., Gonda, X., Rihmer, A., & Döme, P. (2016) · PubMed · Cited by 10
Cited by
Sex differences in the neurochemistry of frontal cortex: Impact of early life stress
Perry, C. J., Campbell, E. J., Drummond, K. D., Lum, J. S., & Kim, J. H. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15208 · Cited by 64
“Neurochemical information is particularly crucial because the vast majority of standard treatments for mental disorders rely on pharmacotherapy that aims to address potential neurochemical imbalances (Bortolasci et al., 2018; World Health Organization, 2001).”
BackgroundOsete, J. R., Akkouh, I. A., de Assis, D. R., Szabó, A., Frei, E., Hughes, T., Smeland, O. B., Steen, N. E., Andreassen, O. A., & Djurovic, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01164-4 · Cited by 61
Faustmann, T. J., Corvace, F., Faustmann, P. M., & Ismail, F. S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab080 · Cited by 33
“From a psychiatric point of view, it was proposed that glial inflammation leads to an increase of glutamate in the synaptic space and that this mechanism could be reduced by LTG (Haroon et al., 2017; Bortolasci et al., 2018).”
The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application
Niu, Z., Yang, L., Wu, X., Zhu, Y., Chen, J., & Fang, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00403-7 · Cited by 32
Beyond evidence‐based treatment of bipolar disorder: Rational pragmatic approaches to management
Post, R. M., Yatham, L. N., Vieta, E., Berk, M., & Nierenberg, A. A. (2019) · Bipolar Disorders · doi:10.1111/bdi.12813 · Cited by 31
Self-citation
Metadata
- Authors
- Bortolasci, C. C., Spolding, B., Callaly, E., Martin, S., Panizzutti, B., Kidnapillai, S., Connor, T., Hasebe, K., Mohebbi, M., Dean, O. M., McGee, S. L., Dodd, S., Gray, L., Berk, M., & Walder, K.
- Affiliations
- Universidade Estadual de Londrina (BR)
- Deakin University (AU)
- Universidade Federal do Rio Grande do Sul (BR)
- Corresponding author
- Walder, Ken
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-19
- Volume
- 21
- Issue
- 6
- Pages
- 582-591
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC6007392
- OpenAlex
- W2790951755
- Cited by
- 25
- References
- 40
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 1
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- Funders
- National Health and Medical Research Council (APP1078928)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- polypharmacy, bipolar disorder, lithium, valproic acid, quetiapine, lamotrigine, drug-drug interactions, inflammation, inflammatory cytokines, microglia, neurons, mitochondrial biogenesis, PGC-1α, ATP5A1, bioenergetics, oxidative stress, superoxide, metabolic flux analysis
- MeSH terms
- Animals, Bipolar Disorder, Cell Line, Drug Interactions, Humans, Inflammation, Lipopolysaccharides, Mitochondria, Neurons, Gene Expression, Cytokines, Microglia, Antimanic Agents, Polypharmacy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.